Pazopanib in advanced and platinum-resistant urothelial cancer: an open-label, single group, phase 2 trialAndrea Necchi, Roberto Salvioni, Patrizia Giannatempo et al.|The Lancet Oncology|2012Cited by 145
Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic FactorsMatteo Santoni, Nicola Battelli, Daniel Y.C. Heng et al.|Cancers|2019Cited by 31